López-Reyes AG, Martínez-Flores K, Clavijo-Cornejo D, Nuño-Lámbarri N, Palestino-Domínguez M, Souza V, Bucio L, Panduro A, Miranda RU, Gómez-Quiroz LE, Gutiérrez-Ruiz MC

Language: Spanish
References: 26
Page: 456-464
PDF size: 316.73 Kb.

ABSTRACT

The increment in the prevalence of obesity incidence in Mexico is leading to the increase in many chronic maladies, including liver diseases. It is well known that lipid-induced liver sensitization is related to the kind of lipid rather than the amount of them in the organ. Cholesterol overload in the liver aggravates the toxic effects of canonical liver insults. However, the status on the repair and survival response elicited by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and the hepatocyte growth factor (HGF) is not completely understood. In the present, work we aimed to figure out the HGF/NADPH oxidase-induced cellular protection in the hepatocyte with a cholesterol overload. Our results show that a hypercholesterolemic diet induced liver damage and steatosis in mice. The hepatocytes isolated from these animals exhibited an increase in basal NADPH oxidase activity, although transcriptional levels of some of its components were decreased. No effect on the oxidase activity was observed in HGF treatments. The protective effect of HGF was abrogated as a result of cholesterol cellular overload, calculated by a survival assay. In conclusion, the cholesterol overload in hepatocytes impairs the HGF/NADPH oxidase-induced cellular protection.

REFERENCES

1. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nut Rev. 2012;70(1):3-21.

2. Koo SH. Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clin Mol Hepatol. 2013;19(3):210-5.

3. Marí M, Caballero F, Colell A, et al. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab. 2006;4(3):185-98.

4. Gutiérrez Ruiz MC, Domínguez Pérez M, Rodríguez González S, Nuno Lámbarri N, Licona Retama C, Gómez-Quiroz LE. [High cholesterol diet modifies the repairing effect of the hepatocyte growth factor]. Gac Med Mex. 2012;148(3):236-42.

5. Caballero F, Fernández A, De Lacy AM, Fernández-Checa JC, Caballería J, García-Ruiz C. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J Hepatol. 2009;50(4):789-96.

6. Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 2008;9(2):125-38.

7. Thorgeirsson SS. The central role of the c-Met pathway in rebuilding the liver. Gut. 2012;61(8):1105-6.

8. Valdes-Arzate A, Luna A, Bucio L, et al. Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism. Free Radic Biol Med. 2009;47(4):424-30.

9. Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol. 2010;11(12):834-48.

10. Enriquez-Cortina C, Almonte-Becerril M, Clavijo-Cornejo D, et al. Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage. Toxicol Sci. 2013;135(1):26-36.

11. Marquardt JU, Seo D, Gomez-Quiroz LE, et al. Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways. Biochim Biophys Acta. 2012;1822(6):942-51.

12. Kaposi-Novak P, Lee JS, Gómez-Quiroz L, Coulouarn C, Factor VM, Thorgeirsson SS. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest. 2006;116(6):1582-95.

13. Takami T, Kaposi-Novak P, Uchida K, et al. Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Res. 2007;67(20): 9844-51.

14. Clavijo-Cornejo D, Enriquez-Cortina C, Lopez-Reyes A, et al. Biphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytes. Biochimie. 2013;95(6):1177-84.

15. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87(1): 245-313.

16. Gomez-Quiroz LE, Factor VM, Kaposi-Novak P, Coulouarn C, Conner EA, Thorgeirsson SS. Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis. J Biol Chem. 2008;283(21):14581-9.

17. Gomez-Quiroz LE, Paris R, Lluis JM, et al. Differential modulation of interleukin 8 by interleukin 4 and interleukin 10 in HepG2 cells treated with acetaldehyde. Liver Int. 2005;25(1):122-30.

18. Pescatore LA, Bonatto D, Forti FL, Sadok A, Kovacic H, Laurindo FR. Protein disulfide isomerase is required for platelet-derived growth factor- induced vascular smooth muscle cell migration, Nox1 NADPH oxidase expression, and RhoGTPase activation. J Biol Chem. 2012; 287(35):29290-300.

19. Fernández Cantón, Sonia B. MN, Yura A, Viguri Uribe R. Sobrepeso y obesidad en menores de 20 años de edad en México. Bol Med Hosp Infant Mex. 2011;68:79-81.

20. OMS. Dieta, Nutrición y Prevención de enfermedades crónicas. Informe de una consulta Mixta de Expertos OMS. 2003.

21. Roth GA, Fihn SD, Mokdad AH, Aekplakorn W, Hasegawa T, Lim SS. High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries. Bull World Health Organ. 2010;89(2):92-101.

22. González G, Fernández JD, Sánchez J, Rodríguez JJ, Quintero AG. Colesterolemia en adolescentes sexo femenino de morelos, México. Revista Chilena de Nutrición. 2005; 32(2):134-41.

23. Juárez-Muñoz IE, Anaya-Florez MS, Mejía-Arangure JM, et al. Niveles séricos de colesterol y lipoproteínas y frecuencia de hipercolesterolemia en un grupo de adolescentes de la Ciudad de México. Bol Med Hosp Infant Mex. 2006;63:162-8.

24. Klaassen CD, Reisman SA. Nrf2 the rescue: effects of the antioxidative/ electrophilic response on the liver. Toxicol Appl Pharmacol. 2010; 244(1):57-65.

25. Niture SK, Kaspar JW, Shen J, Jaiswal AK. Nrf2 signaling and cell survival. Toxicol Appl Pharmacol. 2010;244(1):37-42.

26. Vollrath V, Wielandt AM, Iruretagoyena M, Chianale J. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. Biochem J. 2006;395(3): 599-609.